Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2004, Issue 2, Pages 79-85
http://dx.doi.org/10.1155/S1110724304308107
Research article

Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone

1Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA
2Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA
3Transplantation Biology Program, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA
4Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA

Received 27 September 2003; Revised 16 December 2003; Accepted 22 December 2003

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Dusica Babovic-Vuksanovic, Lydia Petrovic, Bruce E. Knudsen, et al., “Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone,” Journal of Biomedicine and Biotechnology, vol. 2004, no. 2, pp. 79-85, 2004. https://doi.org/10.1155/S1110724304308107.